HIPEC in ovarian cancer Last updated on Sep 17, 2025 Previous Korean HIPEC trial - IDS patients only 2023 Next KEYNOTE-B21: Pembrolizumab Plus Adjuvant Chemotherapy in High-Risk Endometrial Cancer
